Hannah-Shmouni F, Faucz FR and Stratakis CA: Alterations of phosphodiesterases in adrenocortical tumors. Front Endocrinol (Lausanne). 7:1112016. View Article : Google Scholar : PubMed/NCBI

Rall TW and Sutherland EW: Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem. 232:1065–1076. 1958. View Article : Google Scholar : PubMed/NCBI

Butcher RW and Sutherland EW: Adenosine 3′,5′-phosphate in biological materials. I. purification and properties of cyclic 3′,5′-Nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5′-phosphate in human urine. J Biol Chem. 237:1244–1250. 1962. View Article : Google Scholar : PubMed/NCBI

Liu Y, Chen J, Fontes SK, Bautista EN and Cheng Z: Physiological and pathological roles of protein kinase a in the heart. Cardiovasc Res. 118:386–398. 2022. View Article : Google Scholar : PubMed/NCBI

Calamera G, Moltzau LR, Levy FO and Andressen KW: Phosphodiesterases and compartmentation of camp and cgmp signaling in regulation of cardiac contractility in normal and failing hearts. Int J Mol Sci. 23:21452022. View Article : Google Scholar

Levy I, Horvath A, Azevedo M, de Alexandre RB and Stratakis CA: Phosphodiesterase function and endocrine cells: Links to human disease and roles in tumor development and treatment. Curr Opin Pharmacol. 11:689–697. 2011. View Article : Google Scholar

Makhlouf A, Kshirsagar A and Niederberger C: Phosphodiesterase 11: A brief review of structure, expression and function. Int J Impot Res. 18:501–519. 2006. View Article : Google Scholar : PubMed/NCBI

Huang J, Hu B, Xu Z, Ye Y, Wang H, Wang S, Liu Z and Wang J: Selectivity mechanism of phosphodiesterase isoform inhibitor through in silico investigations. J Mol Model. 28:92021. View Article : Google Scholar

Omori K and Kotera J: Overview of PDEs and their regulation. Circ Res. 100:309–327. 2007. View Article : Google Scholar : PubMed/NCBI

Ke H and Wang H: Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity. Curr Top Med Chem. 7:391–403. 2007. View Article : Google Scholar : PubMed/NCBI

Rotella DP: Phosphodiesterase 5 inhibitors: Current status and potential applications. Nat Rev Drug Discov. 1:674–682. 2002. View Article : Google Scholar : PubMed/NCBI

Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, et al: Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 353:2148–2157. 2005. View Article : Google Scholar : PubMed/NCBI

Kleiman RJ, Chapin DS, Christoffersen C, Freeman J, Fonseca KR, Geoghegan KF, Grimwood S, Guanowsky V, Hajós M, Harms JF, et al: Phosphodiesterase 9a regulates central cgmp and modulates responses to cholinergic and monoaminergic perturbation in vivo. J Pharmacol Exp Ther. 341:396–409. 2012. View Article : Google Scholar : PubMed/NCBI

Schmidt CJ: Phosphodiesterase inhibitors as potential cognition enhancing agents. Curr Top Med Chem. 10:222–230. 2010. View Article : Google Scholar : PubMed/NCBI

Blokland A, Schreiber R and Prickaerts J: Improving memory: A role for phosphodiesterases. Curr Pharm Des. 12:2511–2523. 2006. View Article : Google Scholar : PubMed/NCBI

Menniti FS, Faraci WS and Schmidt CJ: Phosphodiesterases in the Cns: Targets for drug development. Nat Rev Drug Discov. 5:660–670. 2006. View Article : Google Scholar : PubMed/NCBI

Hetman JM, Robas N, Baxendale R, Fidock M, Phillips SC, Soderling SH and Beavo JA: Cloning and characterization of two splice variants of human phosphodiesterase 11A. Proc Natl Acad Sci USA. 97:12891–12895. 2000. View Article : Google Scholar : PubMed/NCBI

Fawcett L, Baxendale R, Stacey P, McGrouther C, Harrow I, Soderling S, Hetman J, Beavo JA and Phillips SC: Molecular Cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA. 97:3702–3707. 2000. View Article : Google Scholar : PubMed/NCBI

Yuasa K, Kotera J, Fujishige K, Michibata H, Sasaki T and Omori K: Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression. J Biol Chem. 275:31469–31479. 2000. View Article : Google Scholar : PubMed/NCBI

Yuasa K, Ohgaru T, Asahina M and Omori K: Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): Comparison of rat and human PDE11A Splicing variants. Eur J Biochem. 268:4440–4448. 2001. View Article : Google Scholar : PubMed/NCBI

Weeks JL II, Zoraghi R, Francis SH and Corbin JD: N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization. Biochemistry. 46:10353–10364. 2007. View Article : Google Scholar : PubMed/NCBI

D'Andrea MR, Qiu Y, Haynes-Johnson D, Bhattacharjee S, Kraft P and Lundeen S: Expression of PDE11A in normal and malignant human tissues. J Histochem Cytochem. 53:895–903. 2005. View Article : Google Scholar

Kelly MP: A role for phosphodiesterase 11A (PDE11A) in the formation of social memories and the stabilization of mood. Adv Neurobiol. 17:201–230. 2017. View Article : Google Scholar

Kelly MP: Does phosphodiesterase 11A (PDE11A) hold promise as a future therapeutic target? Curr Pharm Des. 21:389–416. 2015. View Article : Google Scholar : PubMed/NCBI

Pilarzyk K, Farmer R, Porcher L and Kelly MP: The role of PDE11A4 in social isolation-induced changes in intracellular signaling and neuroinflammation. Front Pharmacol. 12:7496282021. View Article : Google Scholar

Wettschureck N and Offermanns S: Mammalian G proteins and their cell type specific functions. Physiol Rev. 85:1159–1204. 2005. View Article : Google Scholar : PubMed/NCBI

Stratakis CA: Mutations of the gene encoding the protein kinase a type I-Alpha regulatory subunit (PRKAR1A) in patients with the ‘complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas’ (Carney Complex). Ann N Y Acad Sci. 968:3–21. 2002. View Article : Google Scholar

Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, René-Corail F, Stergiopoulos S, Bourdeau I, et al: Mutations in regulatory subunit type 1A of cyclic adenosine 5′-Monophosphate-dependent protein kinase (PRKAR1A): Phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab. 94:2085–2091. 2009. View Article : Google Scholar : PubMed/NCBI

Greene EL, Horvath AD, Nesterova M, Giatzakis C, Bossis I and Stratakis CA: In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay. Hum Mutat. 29:633–639. 2008. View Article : Google Scholar

Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, et al: Molecular analysis of the cyclic AMP-Dependent Protein Kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: Augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. Am J Hum Genet. 71:1433–1442. 2002. View Article : Google Scholar

Horvath A, Bertherat J, Groussin L, Guillaud-Bataille M, Tsang K, Cazabat L, Libé R, Remmers E, René-Corail F, Faucz FR, et al: Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): An update. Hum Mutat. 31:369–379. 2010. View Article : Google Scholar

Sandrini F and Stratakis C: Clinical and molecular genetics of carney complex. Mol Genet Metab. 78:83–92. 2003. View Article : Google Scholar : PubMed/NCBI

Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS and Stratakis CA: Mutations of the gene encoding the protein kinase a type I-alpha regulatory subunit in patients with the carney complex. Nat Genet. 26:89–92. 2000. View Article : Google Scholar

Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E and Spiegel AM: Activating mutations of the stimulatory G protein in the McCune-albright syndrome. N Engl J Med. 325:1688–1695. 1991. View Article : Google Scholar : PubMed/NCBI

Stewart V and Yanofsky C: Role of leader peptide synthesis in tryptophanase operon expression in Escherichia Coli K-12. J Bacteriol. 167:383–386. 1986. View Article : Google Scholar

Velterop JS, Sellink E, Meulenberg JJ, David S, Bulder I and Postma PW: Synthesis of pyrroloquinoline quinone in vivo and in vitro and detection of an intermediate in the biosynthetic pathway. J Bacteriol. 177:5088–5098. 1995. View Article : Google Scholar

Meulenberg JJ, Sellink E, Riegman NH and Postma PW: Nucleotide sequence and structure of the klebsiella pneumoniae Pqq operon. Mol Gen Genet. 232:284–294. 1992. View Article : Google Scholar

Roelofs J, Smith JL and Van Haastert PJ: Cgmp signalling: Different ways to create a pathway. Trends Genet. 19:132–134. 2003. View Article : Google Scholar

Ochman H: Distinguishing the ORFs from the ELFs: Short bacterial genes and the annotation of genomes. Trends Genet. 18:335–337. 2002. View Article : Google Scholar

Yanofsky C: Transcription Attenuation. J Biol Chem. 263:609–612. 1988. View Article : Google Scholar : PubMed/NCBI

You JY, Liu XW, Bao YX, Shen ZN, Wang Q, He GY, Lu J, Zhang JG, Chen JW and Liu PQ: A novel phosphodiesterase 9A inhibitor LW33 protects against ischemic stroke through the cGMP/PKG/CREB Pathway. Eur J Pharmacol. 925:1749872022. View Article : Google Scholar

Libe R, Fratticci A, Coste J, Tissier F, Horvath A, Ragazzon B, Rene-Corail F, Groussin L, Bertagna X, Raffin-Sanson ML, et al: Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin Cancer Res. 14:4016–4024. 2008. View Article : Google Scholar : PubMed/NCBI

Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP, et al: A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet. 38:794–800. 2006. View Article : Google Scholar

Horvath A, Korde L, Greene MH, Libe R, Osorio P, Faucz FR, Raffin-Sanson ML, Tsang KM, Drori-Herishanu L, Patronas Y, et al: Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors. Cancer Res. 69:5301–5306. 2009. View Article : Google Scholar : PubMed/NCBI

de Alexandre RB, Horvath AD, Szarek E, Manning AD, Leal LF, Kardauke F, Epstein JA, Carraro DM, Soares FA, Apanasovich TV, et al: Phosphodiesterase Sequence variants may predispose to prostate cancer. Endocr Relat Cancer. 22:519–530. 2015. View Article : Google Scholar : PubMed/NCBI

Lefievre L, de Lamirande E and Gagnon C: Presence of Cyclic nucleotide phosphodiesterases PDE1A, existing as a stable complex with calmodulin, and PDE3A in human spermatozoa. Biol Reprod. 67:423–430. 2002. View Article : Google Scholar : PubMed/NCBI

Fidock M, Miller M and Lanfear J: Isolation and differential tissue distribution of two human cDNAs encoding PDE1 splice variants. Cell Signal. 14:53–60. 2002. View Article : Google Scholar

Michibata H, Yanaka N, Kanoh Y, Okumura K and Omori K: Human Ca2+/Calmodulin-dependent phosphodiesterase PDE1A: Novel splice variants, their specific expression, genomic organization, and chromosomal localization. Biochim Biophys Acta. 1517:278–287. 2001. View Article : Google Scholar

Loughney K, Martins TJ, Harris EA, Sadhu K, Hicks JB, Sonnenburg WK, Beavo JA and Ferguson K: Isolation and Characterization of CDNAs corresponding to two human calcium, calmodulin-regulated, 3′,5′-cyclic nucleotide phosphodiesterases. J Biol Chem. 271:796–806. 1996. View Article : Google Scholar : PubMed/NCBI

Kanda N and Watanabe S: Regulatory roles of adenylate cyclase and cyclic nucleotide phosphodiesterases 1 and 4 in interleukin-13 production by activated human T cells. Biochem Pharmacol. 62:495–507. 2001. View Article : Google Scholar

Yan C, Zhao AZ, Bentley JK, Loughney K, Ferguson K and Beavo JA: Molecular cloning and characterization of a calmodulin-dependent phosphodiesterase enriched in olfactory sensory neurons. Proc Natl Acad Sci USA. 92:9677–9681. 1995. View Article : Google Scholar : PubMed/NCBI

Nikolaev VO, Gambaryan S, Engelhardt S, Walter U and Lohse MJ: Real-Time Monitoring of the PDE2 activity of live cells: Hormone-stimulated camp hydrolysis is faster than hormone-stimulated camp synthesis. J Biol Chem. 280:1716–1719. 2005. View Article : Google Scholar : PubMed/NCBI

Maurice DH, Palmer D, Tilley DG, Dunkerley HA, Netherton SJ, Raymond DR, Elbatarny HS and Jimmo SL: Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system. Mol Pharmacol. 64:533–546. 2003. View Article : Google Scholar

Degerman E, Belfrage P and Manganiello VC: Structure, localization, and regulation of cgmp-inhibited phosphodiesterase (PDE3). J Biol Chem. 272:6823–6826. 1997. View Article : Google Scholar : PubMed/NCBI

Mongillo M, Tocchetti CG, Terrin A, Lissandron V, Cheung YF, Dostmann WR, Pozzan T, Kass DA, Paolocci N, Houslay MD and Zaccolo M: Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an No/cGMP-dependent pathway. Circ Res. 98:226–234. 2006. View Article : Google Scholar : PubMed/NCBI

Bender AT, Ostenson CL, Giordano D and Beavo JA: Differentiation of human monocytes in vitro with granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor produces distinct changes in cGMP phosphodiesterase expression. Cell Signal. 16:365–374. 2004. View Article : Google Scholar

Seybold J, Thomas D, Witzenrath M, Boral S, Hocke AC, Burger A, Hatzelmann A, Tenor H, Schudt C, Krüll M, et al: Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: Role in endothelial hyperpermeability. Blood. 105:3569–3576. 2005. View Article : Google Scholar : PubMed/NCBI

Domek-Lopacinska K and Strosznajder JB: The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging. Brain Res. 1216:68–77. 2008. View Article : Google Scholar : PubMed/NCBI

de Oliveira SK and Smolenski A: Phosphodiesterases link the aryl hydrocarbon receptor complex to cyclic nucleotide signaling. Biochem Pharmacol. 77:723–733. 2009. View Article : Google Scholar

Rena G, Begg F, Ross A, MacKenzie C, McPhee I, Campbell L, Huston E, Sullivan M and Houslay MD: Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10. Mol Pharmacol. 59:996–1011. 2001. View Article : Google Scholar

Wang P, Wu P, Ohleth KM, Egan RW and Billah MM: Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol. 56:170–174. 1999. View Article : Google Scholar

Bolger G, Michaeli T, Martins T, St John T, Steiner B, Rodgers L, Riggs M, Wigler M and Ferguson K: A family of human phosphodiesterases homologous to the dunce learning and memory gene product of drosophila melanogaster are potential targets for antidepressant drugs. Mol Cell Biol. 13:6558–6571. 1993. View Article : Google Scholar

Dunkern TR and Hatzelmann A: The effect of sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5. Cell Signal. 17:331–339. 2005. View Article : Google Scholar

Prickaerts J, Sik A, van Staveren WC, Koopmans G, Steinbusch HW, van der Staay FJ, de Vente J and Blokland A: Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem Int. 45:915–928. 2004. View Article : Google Scholar

Miller CL and Yan C: Targeting cyclic nucleotide phosphodiesterase in the heart: Therapeutic implications. J Cardiovasc Transl Res. 3:507–515. 2010. View Article : Google Scholar : PubMed/NCBI

Ridge KD, Abdulaev NG, Sousa M and Palczewski K: Phototransduction: Crystal clear. Trends Biochem Sci. 28:479–487. 2003. View Article : Google Scholar

Morin F, Lugnier C, Kameni J and Voisin P: Expression and role of phosphodiesterase 6 in the chicken pineal gland. J Neurochem. 78:88–99. 2001. View Article : Google Scholar : PubMed/NCBI

Bloom TJ and Beavo JA: Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants. Proc Natl Acad Sci USA. 93:14188–14192. 1996. View Article : Google Scholar : PubMed/NCBI

Han P, Zhu X and Michaeli T: Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J Biol Chem. 272:16152–16157. 1997. View Article : Google Scholar : PubMed/NCBI

Sasaki T, Kotera J and Omori K: Transcriptional activation of phosphodiesterase 7B1 by dopamine d1 receptor stimulation through the cyclic AMP/Cyclic AMP-dependent protein kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons. J Neurochem. 89:474–483. 2004. View Article : Google Scholar : PubMed/NCBI

Glavas NA, Ostenson C, Schaefer JB, Vasta V and Beavo JA: T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3. Proc Natl Acad Sci USA. 98:6319–6324. 2001. View Article : Google Scholar : PubMed/NCBI

Patrucco E, Albergine MS, Santana LF and Beavo JA: Phosphodiesterase 8A (PDE8A) regulates excitation-contraction coupling in ventricular myocytes. J Mol Cell Cardiol. 49:330–333. 2010. View Article : Google Scholar

Mehats C, Andersen CB, Filopanti M, Jin SL and Conti M: Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab. 13:29–35. 2002. View Article : Google Scholar : PubMed/NCBI

Hayashi M, Matsushima K, Ohashi H, Tsunoda H, Murase S, Kawarada Y and Tanaka T: Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3′,5′-cyclic nucleotide phosphodiesterase. Biochem Biophys Res Commun. 250:751–756. 1998. View Article : Google Scholar : PubMed/NCBI

Hayashi M, Shimada Y, Nishimura Y, Hama T and Tanaka T: Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene. Biochem Biophys Res Commun. 297:1253–1258. 2002. View Article : Google Scholar : PubMed/NCBI

Horvath A, Giatzakis C, Tsang K, Greene E, Osorio P, Boikos S, Libè R, Patronas Y, Robinson-White A, Remmers E, et al: A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: A novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet. 16:1245–1253. 2008. View Article : Google Scholar

Rentero C, Monfort A and Puigdomenech P: Identification and distribution of different mRNA variants produced by differential splicing in the human phosphodiesterase 9A gene. Biochem Biophys Res Commun. 301:686–692. 2003. View Article : Google Scholar : PubMed/NCBI

Furukawa T, Youssef EM, Yatsuoka T, Yokoyama T, Makino N, Inoue H, Fukushige S, Hoshi M, Hayashi Y, Sunamura M and Horii A: Cloning and characterization of the human Udp-N-Acetylglucosamine: Alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV-Homologue (hGnT-IV-H) gene. J Hum Genet. 44:397–401. 1999. View Article : Google Scholar

Kelly MP, Logue SF, Brennan J, Day JP, Lakkaraju S, Jiang L, Zhong X, Tam M, Sukoff Rizzo SJ, Platt BJ, et al: Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes. Proc Natl Acad Sci USA. 107:8457–8462. 2010. View Article : Google Scholar : PubMed/NCBI

Kleppisch T: Phosphodiesterases in the central nervous system. Handb Exp Pharmacol. 71–92. 2009. View Article : Google Scholar

Knott EP, Assi M, Rao SN, Ghosh M and Pearse DD: Phosphodiesterase inhibitors as a therapeutic approach to neuroprotection and repair. Int J Mol Sci. 18:6962017. View Article : Google Scholar

Libe R, Horvath A, Vezzosi D, Fratticci A, Coste J, Perlemoine K, Ragazzon B, Guillaud-Bataille M, Groussin L, Clauser E, et al: Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with carney complex (CNC) Caused by PRKAR1A Mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype. J Clin Endocrinol Metab. 96:E208–E214. 2011. View Article : Google Scholar : PubMed/NCBI

Jager R, Russwurm C, Schwede F, Genieser HG, Koesling D and Russwurm M: Activation of PDE10 and PDE11 phosphodiesterases. J Biol Chem. 287:1210–1219. 2012. View Article : Google Scholar : PubMed/NCBI

Pitsava G and Stratakis CA: Genetic alterations in benign adrenal tumors. Biomedicines. 10:10412022. View Article : Google Scholar : PubMed/NCBI

Hsiao HP, Kirschner LS, Bourdeau I, Keil MF, Boikos SA, Verma S, Robinson-White AJ, Nesterova M, Lacroix A and Stratakis CA: Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab. 94:2930–2937. 2009. View Article : Google Scholar : PubMed/NCBI

Horvath A, Giatzakis C, Robinson-White A, Boikos S, Levine E, Griffin K, Stein E, Kamvissi V, Soni P, Bossis I, et al: Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res. 66:11571–11575. 2006. View Article : Google Scholar : PubMed/NCBI

Pathak A, Stewart DR, Faucz FR, Xekouki P, Bass S, Vogt A, Zhang X, Boland J, Yeager M, Loud JT, et al: Rare inactivating PDE11A variants associated with testicular germ cell tumors. Endocr Relat Cancer. 22:909–917. 2015. View Article : Google Scholar : PubMed/NCBI

Dal J, Nielsen EH, Klose M, Feldt-Rasmussen U, Andersen M, Vang S, Korbonits M and Jørgensen JOL: Phenotypic and genotypic features of a large kindred with a germline AIP variant. Clin Endocrinol (Oxf). 93:146–153. 2020. View Article : Google Scholar : PubMed/NCBI

Pinto EM, Faucz FR, Paza LZ, Wu G, Fernandes ES, Bertherat J, Stratakis CA, Lalli E, Ribeiro RC, Rodriguez-Galindo C, et al: Germline variants in phosphodiesterase genes and genetic predisposition to pediatric adrenocortical tumors. Cancers (Basel). 12:5062020. View Article : Google Scholar

Faucz FR, Horvath A, Rothenbuhler A, Almeida MQ, Libe R, Raffin-Sanson ML, Bertherat J, Carraro DM, Soares FA, Molina Gde C, et al: Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer. J Clin Endocrinol Metab. 96:E135–E140. 2011. View Article : Google Scholar : PubMed/NCBI

Dono A, Nickles J, Rodriguez-Armendariz AG, McFarland BC, Ajami NJ, Ballester LY, Wargo JA and Esquenazi Y: Glioma and the gut-brain axis: Opportunities and future perspectives. Neurooncol Adv. 4:vdac0542022.PubMed/NCBI

Schwartz KA, Noel M, Nikolai M, Olson LK, Hord NG, Zakem M, Clark J, Elnabtity M, Figueroa B and Chang HT: Long term survivals in aggressive primary brain malignancies treated with an adjuvant ketogenic diet. Front Nutr. 9:7707962022. View Article : Google Scholar : PubMed/NCBI

Burns TC, Awad AJ, Li MD and Grant GA: Radiation-induced brain injury: Low-hanging fruit for neuroregeneration. Neurosurg Focus. 40:E32016. View Article : Google Scholar : PubMed/NCBI

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI

Lee H, Park S, Kong G, Kwon SH, Park J, Park J and Kim SH: Phosphodiesterase 11A (PDE11A), a potential biomarker for glioblastoma. Toxicol Res. 2022. View Article : Google Scholar

Rothenbuhler A, Horvath A, Libe R, Faucz FR, Fratticci A, Raffin Sanson ML, Vezzosi D, Azevedo M, Levy I, Almeida MQ, et al: Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours. Clin Endocrinol (Oxf). 77:195–199. 2012. View Article : Google Scholar : PubMed/NCBI

Hou Y, Wren A, Mylarapu N, Browning K, Islam BN, Wang R, Vega KJ and Browning DD: Inhibition of colon cancer cell growth by phosphodiesterase inhibitors is independent of cGMP Signaling. J Pharmacol Exp Ther. 381:42–53. 2022. View Article : Google Scholar : PubMed/NCBI

Di Iorio P, Ronci M, Giuliani P, Caciagli F, Ciccarelli R, Caruso V, Beggiato S and Zuccarini M: Pros and cons of pharmacological manipulation of cGMP-PDEs in the prevention and treatment of breast cancer. Int J Mol Sci. 23:2622021. View Article : Google Scholar

Vezzosi D, Cartier D, Regnier C, Otal P, Bennet A, Parmentier F, Plantavid M, Lacroix A, Lefebvre H and Caron P: Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol. 156:21–31. 2007. View Article : Google Scholar

Vezzosi D, Libe R, Baudry C, Rizk-Rabin M, Horvath A, Levy I, René-Corail F, Ragazzon B, Stratakis CA, Vandecasteele G and Bertherat J: Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): Functional variants may contribute to genetic susceptibility of bilateral adrenal tumors. J Clin Endocrinol Metab. 97:E2063–E2069. 2012. View Article : Google Scholar : PubMed/NCBI

Peverelli E, Ermetici F, Filopanti M, Elli FM, Ronchi CL, Mantovani G, Ferrero S, Bosari S, Beck-Peccoz P, Lania A and Spada A: Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients. Eur J Endocrinol. 161:687–694. 2009. View Article : Google Scholar

Pathak G, Agostino MJ, Bishara K, Capell WR, Fisher JL, Hegde S, Ibrahim BA, Pilarzyk K, Sabin C, Tuczkewycz T, et al: PDE11A negatively regulates lithium responsivity. Mol Psychiatry. 22:1714–1724. 2017. View Article : Google Scholar : PubMed/NCBI

Qin W, Zhou A, Zuo X, Jia L, Li F, Wang Q, Li Y, Wei Y, Jin H, Cruchaga C, et al: Exome Sequencing Revealed PDE11A as a novel candidate gene for early-onset Alzheimer's disease. Hum Mol Genet. 30:811–822. 2021. View Article : Google Scholar

Pilarzyk K, Klett J, Pena EA, Porcher L, Smith AJ and Kelly MP: Loss of function of phosphodiesterase 11A4 shows that recent and remote long-term memories can be uncoupled. Curr Biol. 29:2307–2321. e52019. View Article : Google Scholar

Hegde S, Capell WR, Ibrahim BA, Klett J, Patel NS, Sougiannis AT and Kelly MP: Phosphodiesterase 11A (PDE11A), enriched in ventral hippocampus neurons, is required for consolidation of social but not nonsocial memories in mice. Neuropsychopharmacology. 41:2920–2931. 2016. View Article : Google Scholar : PubMed/NCBI

Loughney K, Taylor J and Florio VA: 3′,5′-cyclic nucleotide phosphodiesterase 11A: Localization in human tissues. Int J Impot Res. 17:320–325. 2005. View Article : Google Scholar : PubMed/NCBI

Wayman C, Phillips S, Lunny C, Webb T, Fawcett L, Baxendale R and Burgess G: Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology. Int J Impot Res. 17:216–223. 2005. View Article : Google Scholar : PubMed/NCBI